Circ_0067835 Knockdown Enhances the Radiosensitivity of Colorectal Cancer by miR-296-5p/IGF1R Axis

References

• Cummings OW. Pathology of the adenoma-carcinoma sequence: from aberrant crypt focus to invasive carcinoma. Semin Gastrointest Dis. 2000;11(4):229–237.
   PubMedGoogle Scholar
• Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer. Lancet. 2019;394(10207):1467–1480. doi:10.1016/S0140-6736(19)32319-0
   PubMed Web of Science ®Google Scholar
• Ohhara Y, Fukuda N, Takeuchi S, et al. Role of targeted therapy in metastatic colorectal cancer. World J Gastrointest Oncol. 2016;8(9):642–655. doi:10.4251/wjgo.v8.i9.642
   PubMed Web of Science ®Google Scholar
• Clifford R, Govindarajah N, Parsons JL, et al. Systematic review of treatment intensification using novel agents for chemoradiotherapy in rectal cancer. Br J Surg. 2018;105(12):1553–1572. doi:10.1002/bjs.10993
   PubMed Web of Science ®Google Scholar
• Cousins A, Thompson SK, Wedding AB, et al. Clinical relevance of novel imaging technologies for sentinel lymph node identification and staging. Biotechnol Adv. 2014;32(2):269–279. doi:10.1016/j.biotechadv.2013.10.011
   PubMed Web of Science ®Google Scholar
• Munakata K, Uemura M, Tanaka S, et al. Cancer stem-like properties in colorectal cancer cells with low proteasome activity. Clin Cancer Res. 2016;22(21):5277–5286. doi:10.1158/1078-0432.CCR-15-1945
   PubMed Web of Science ®Google Scholar
• Kelley K, Ruhl R, Rana S, et al. Understanding and resetting radiation sensitivity in rectal cancer. Ann Surg. 2017;266(4):610–616. doi:10.1097/SLA.0000000000002409
   PubMed Web of Science ®Google Scholar
• Dearling J, Qureshi U, Begent R, et al. Combining radioimmunotherapy with antihypoxia therapy 2-deoxy-D-glucose results in reduction of therapeutic efficacy. Clin Cancer Res. 2007;13(6):1903–1910. doi:10.1158/1078-0432.CCR-06-2094
   PubMed Web of Science ®Google Scholar
• Yin Y, Long J, He Q, et al. Emerging roles of circRNA in formation and progression of cancer. J Cancer. 2019;10(21):5015–5021. doi:10.7150/jca.30828
   PubMed Web of Science ®Google Scholar
• Zhong Y, Du Y, Yang X, et al. Circular RNAs function as ceRNAs to regulate and control human cancer progression. Mol Cancer. 2018;17(1):79. doi:10.1186/s12943-018-0827-8
   PubMed Web of Science ®Google Scholar
• Zhang ZJ, Zhang YH, Qin XJ, et al. Circular RNA circDENND4C facilitates proliferation, migration and glycolysis of colorectal cancer cells through miR-760/GLUT1 axis. Eur Rev Med Pharmacol Sci. 2020;24(5):2387–2400. doi:10.26355/eurrev_202003_20506
   PubMed Web of Science ®Google Scholar
• Du S, Zhang P, Ren W, et al. Circ-ZNF609 accelerates the radioresistance of prostate cancer cells by promoting the glycolytic metabolism through miR-501-3p/HK2 axis. Cancer Manag Res. 2020;12:7487–7499. doi:10.2147/CMAR.S257441
   PubMed Web of Science ®Google Scholar
• Jin Y, Su Z, Sheng H, et al. Circ_0086720 knockdown strengthens the radiosensitivity of non-small cell lung cancer via mediating the miR-375/SPIN1 axis. Neoplasma. 2020. doi:10.4149/neo_2020_200331N333
   Web of Science ®Google Scholar
• Liu Y, Chang Y, Cai Y. Circ_0067835 sponges miR-324-5p to induce HMGA1 expression in endometrial carcinoma cells. J Cell Mol Med. 2020.
   Web of Science ®Google Scholar
• Feng W, Gong H, Wang Y, et al. circIFT80 functions as a ceRNA of miR-1236-3p to promote colorectal cancer progression. Mol Ther Nucleic Acids. 2019;18:375–387. doi:10.1016/j.omtn.2019.08.024
   PubMedGoogle Scholar
• Yu CY, Kuo HC. The emerging roles and functions of circular RNAs and their generation. J Biomed Sci. 2019;26(1):29. doi:10.1186/s12929-019-0523-z
   PubMedGoogle Scholar
• Tintut Y, Demer L. Exosomes: nanosized cellular messages. Circ Res. 2015;116(8):1281–1283. doi:10.1161/CIRCRESAHA.115.306324
   PubMed Web of Science ®Google Scholar
• Liu D, Kang H, Gao M, et al. Exosome-transmitted circ_MMP2 promotes hepatocellular carcinoma metastasis by upregulating MMP2. Mol Oncol. 2020;14(6):1365–1380. doi:10.1002/1878-0261.12637
   PubMed Web of Science ®Google Scholar
• Shi DM, Li LX, Bian XY, et al. miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling. J Exp Clin Cancer Res. 2018;37(1):294. doi:10.1186/s13046-018-0957-2
   PubMedGoogle Scholar
• Chen Y, Gao H, Li Y. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway. Mol Cell Endocrinol. 2020;500:110634. doi:10.1016/j.mce.2019.110634
   PubMed Web of Science ®Google Scholar
• Ma C, Ma N, Qin L, et al. DICER1-AS1 promotes the malignant behaviors of colorectal cancer cells by regulating miR-296-5p/STAT3 axis. Cancer Manag Res. 2020;12:10035–10046. doi:10.2147/CMAR.S252786
   PubMed Web of Science ®Google Scholar
• Wang L, Wu H, Chu F, et al. Knockdown of circ_0000512 inhibits cell proliferation and promotes apoptosis in colorectal cancer by regulating miR-296-5p/RUNX1 axis. Onco Targets Ther. 2020;13:7357–7368. doi:10.2147/OTT.S250495
   PubMed Web of Science ®Google Scholar
• Ma Z, Cai Y, Zhang L, et al. LINC00319 promotes cervical cancer progression via targeting miR-147a/IGF1R pathway. Cancer Biother Radiopharm. 2020. doi:10.1089/cbr.2020.3722
   Web of Science ®Google Scholar
• Shin HC, Bae YK, Gu MJ, et al. Expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor is associated with the favorable clinicopathologic parameters in small intestinal carcinomas. Pathobiology. 2013;80(5):265–270. doi:10.1159/000350309
   PubMed Web of Science ®Google Scholar
• Mendivil A, Zhou C, Cantrell LA, et al. AMG 479, a novel IGF-1-R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathways. Reprod Sci. 2011;18(9):832–841. doi:10.1177/1933719111398501
   PubMed Web of Science ®Google Scholar
• Bahrami A, Khazaei M, Hasanzadeh M, et al. Therapeutic potential of targeting PI3K/AKT pathway in treatment of colorectal cancer: rational and progress. J Cell Biochem. 2018;119(3):2460–2469. doi:10.1002/jcb.25950
   PubMed Web of Science ®Google Scholar
• Song G, Xu S, Zhang H, et al. TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway. J Exp Clin Cancer Res. 2016;35(1):148. doi:10.1186/s13046-016-0427-7
   PubMed Web of Science ®Google Scholar